Sustained virological response in HIV/HCV Co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.

Elsevier, Journal of Infection, 4(68), p. 372-377

Journal article published in 2013 by Antonio Rivero-Juarez, Karin Neukam, Pablo Labarga, Angela Camacho, Juan Macias

, Pablo Barreiro, Julián Torre-Cisneros, Juan A. Pineda, Vicente Soriano, Antonio Rivero

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by